Analysis of HER Family (HER1-4) Expression as a Biomarker in Combination Therapy with Pertuzumab, Trastuzumab and Docetaxel for Advanced HER2-positive Breast Cancer

Takada, K; Kashiwagi, S; Goto, W; Asano, Y; Morisaki, T; Fujita, H; Takashima, T; Ohsawa, M; Hirakawa, K; Ohira, M

Kashiwagi, S (reprint author), Osaka City Univ, Grad Sch Med, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.

ANTICANCER RESEARCH, 2018; 38 (4): 2285

Abstract

Background: Chemotherapy with trastuzumab, pertuzumab and docetaxel (TPD regimen) is now strongly recommended as a treatment option for first-line the......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索